Nov 15, 2021 / 09:30PM GMT
Unidentified Participant -
Good afternoon, and welcome to the CymaBay Therapeutics post-AASLD KOL call. (Operator Instructions) As a reminder, this event is being recorded, and a replay will be made available on the CymaBay website following the conclusion of the event.
I would now like to turn the call over to your host, Dr. Dennis Kim, Chief Medical Officer of CymaBay Therapeutics. Please go ahead.
Dennis D. Kim - CymaBay Therapeutics, Inc. - Chief Medical Officer
Thank you. Thank you all for joining CymaBay's Key Opinion Leader webinar of the 2 clinical abstracts presented at the 2021 Virtual AASLD Scientific Conference.
Today is the last day of the conference, and we're pleased and honored to have 2 stalwarts in the hepatology field, Doctors Marlyn Mayo and Cynthia Levy, with us today.
As you may know already, CymaBay is currently in the midst of recruiting our seladelpar Phase III registration study called RESPONSE in patients with primary biliary cholangitis, or PBC. In the meanwhile, with the help of our close advisers and
Cymabay Therapeutics Inc Host Post-AASLD Key Opinion Leader Webinar Call Transcript
Nov 16, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers